SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys free cash flow 1990–2026

Synopsys's free cash flow in Q3 FY2026, the three months to 31 July 2026, was 746.27M USD, up 18.0% on the same quarter a year before. Synopsys's free cash flow over the last twelve months was 2.79B USD, up 114.2% on the twelve months before. In fiscal year 2025 it was 1.35B USD, up 5.1% on the year before.

Last updated 6 Nov 2026 · Next report 8 Dec 2026

Free cash flow

Free cash flow · +12.8% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM31 Jul 20262.79B+114.21%29.63%2.98B-190.64M15.78
FY202531 Oct 20251.35B+5.09%19.13%1.52B-169.45M8.34
FY202431 Oct 20241.28B-15.06%20.95%1.41B-123.16M8.23
FY202331 Oct 20231.51B-5.52%28.42%1.70B-191.82M9.74
FY202231 Oct 20221.60B+14.53%34.66%1.74B-139.08M10.22
FY202131 Oct 20211.40B+67.78%33.23%1.49B-95.74M8.88
FY202031 Oct 2020832.55M+39.19%22.59%991.31M-158.76M5.35
FY201931 Oct 2019598.13M+85.58%17.80%800.51M-202.39M3.88
FY201831 Oct 2018322.31M-42.55%10.33%424.23M-101.93M2.10
FY201731 Oct 2017561.01M+8.81%20.59%634.57M-73.55M3.62
FY201631 Oct 2016515.60M+27.46%21.28%586.64M-71.04M3.33
FY201531 Oct 2015404.51M-8.90%18.04%495.16M-90.65M2.56
FY201431 Oct 2014444.04M+3.84%21.58%550.95M-106.91M2.82
FY201331 Oct 2013427.64M-0.22%21.79%496.71M-69.07M2.73
FY201231 Oct 2012428.58M+12.76%24.41%486.07M-57.49M2.85
FY201131 Oct 2011380.09M+27.14%24.75%440.32M-60.23M2.53
FY201031 Oct 2010298.96M+51.67%21.65%341.04M-42.08M1.97
FY200931 Oct 2009197.11M-31.88%14.49%236.71M-39.60M1.35
FY200831 Oct 2008289.35M-25.08%21.64%331.09M-41.74M1.96
FY200731 Oct 2007386.19M+149.99%31.85%433.48M-47.29M2.58
FY200631 Oct 2006154.48M-31.53%14.10%205.89M-51.41M1.07
FY200531 Oct 2005225.63M+3.01%22.75%269.19M-43.56M1.56
FY200431 Oct 2004219.03M-35.84%20.06%264.04M-45.01M1.38
FY200331 Oct 2003341.39M—29.01%391.53M-50.15M2.07
FY200231 Oct 2002-229.80M-207.72%-25.35%-181.05M-48.76M-1.74
FY200131 Oct 2001213.34M+158.23%31.36%295.83M-82.49M1.65
FY200031 Oct 200082.62M-25.57%10.54%151.12M-68.50M0.58
FY199930 Sept 1999111.00M+99.28%13.77%223.30M-112.30M0.76
FY199830 Sept 199855.70M+1.09%7.76%144.10M-88.40M0.40
FY199730 Sept 199755.10M+12.45%8.52%109.60M-54.50M0.42
FY199630 Sept 199649.00M-12.19%9.32%88.30M-39.30M0.59
FY199530 Sept 199555.80M+32.23%21.02%76.70M-20.90M0.59
FY199430 Sept 199442.20M+12.53%21.53%55.20M-13.00M0.57
FY199330 Sept 199337.50M+188.46%34.72%47.10M-9.60M0.60
FY199230 Sept 199213.00M+490.91%20.63%17.20M-4.20M0.22
FY199130 Sept 19912.20M-55.10%5.43%5.40M-3.20M0.04
FY199030 Sept 19904.90M—22.17%6.00M-1.10M0.11

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Synopsys's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.